What is the 13F Pro Quality Score for VSEE?

13F Pro ranks VSEE HEALTH, INC. (VSEE) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View VSEE's current score at https://13fpro.ai/research/VSEE (free sign-up required for the full ranking).

Where does 13F Pro source VSEE data?

All VSEE HEALTH, INC. fundamentals and ownership data come directly from SEC EDGAR. VSEE HEALTH, INC. files with the SEC under CIK 1864531. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is VSEE in?

VSEE HEALTH, INC. (VSEE) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is VSEE research updated on 13F Pro?

VSEE's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

VSEE HEALTH, INC.(VSEE)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1864531 VSEE stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $14.6M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

VSEE Stock Analysis & AI Quality Score

AI stock analysis and institutional research for VSEE HEALTH, INC. (VSEE), a Healthcare sector company. VSEE is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $14.6m in revenue. Based on the latest XBRL financial filings (Q1 2026), VSEE HEALTH, INC. reports quarterly revenue of $3.2M, net income of $-2.6M, free cash flow of $-2.5M. Top institutional holders of VSEE by reported 13-F value include ARMISTICE CAPITAL,, GEODE CAPITAL MANAGEMENT,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. VSEE trades on the Nasdaq exchange and files with the SEC under CIK 1864531. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate VSEE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for VSEE HEALTH, INC. directly from SEC EDGAR.

Revenue

Q1 2026

$3.2M

Net Income

Q1 2026

$-2.6M

Free Cash Flow

Q1 2026

$-2.5M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+40.3% YoY

$14.6MFY 2025

FY22 —FY23 $5.8MFY24 $10.4MFY25 $14.6M

Net Income

+74.5% YoY

$-14.7MFY 2025

FY22 $-3.2MFY23 $-1.9MFY24 $-57.7MFY25 $-14.7M

Operating Income

+84.6% YoY

$-9.6MFY 2025

FY22 $-3.6MFY23 $-1.9MFY24 $-62.2MFY25 $-9.6M

EPS (Diluted)

+74.2% YoY

$-0.73FY 2025

FY22 $-0.13FY23 $-0.19FY24 $-2.83FY25 $-0.73

Total Assets

+12.1% YoY

$22.4MFY 2025

FY22 $7.6MFY23 $830.8KFY24 $20.0MFY25 $22.4M

Total Debt

+37.7% YoY

$3.3MFY 2025

FY22 —FY23 $440.0KFY24 $2.4MFY25 $3.3M

Op. Cash Flow

+40.5% YoY

$-3.4MFY 2025

FY22 $-1.4MFY23 $-632.6KFY24 $-5.8MFY25 $-3.4M

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Revenue	$14.6M +40.3%	$10.4M +80.7%	$5.8M	—
Net Income	$-14.7M +74.5%	$-57.7M -2945.5%	$-1.9M +41.6%	$-3.2M
Operating Income	$-9.6M +84.6%	$-62.2M -3217.2%	$-1.9M +47.9%	$-3.6M
EPS (Diluted)	$-0.73 +74.2%	$-2.83 -1386.8%	$-0.19 -52.0%	$-0.13
Total Assets	$22.4M +12.1%	$20.0M +2306.4%	$830.8K -89.1%	$7.6M
Total Debt	$3.3M +37.7%	$2.4M +438.3%	$440.0K	—
Operating Cash Flow	$-3.4M +40.5%	$-5.8M -815.2%	$-632.6K +54.5%	$-1.4M

AI Insight: VSEE Financial Trends

VSee Health continues unprofitable operations with stagnant $3–4M quarterly revenue and persistent operating losses despite marginal improvements in net income volatility.

• Net income losses narrowed from $52M in Q3 2024 to $3M in Q1 2026, indicating improved cost control or reduced one-time charges.

• Revenue flat at $3–4M per quarter over 8 quarters; no growth trajectory evident.

• Operating cash outflow reduced to $2M in Q4 2025 and Q1 2026 versus $3M in Q2 2024.

⚠ Persistent negative equity from Q1 2025 onward ($3M to $6M deficit) signals shareholder value erosion and solvency stress.

⚠ Operating income remains deeply negative ($2M–$3M loss per quarter); path to profitability unclear.

AI Insight: VSEE Ratio Trends

VSEE Health deteriorated sharply into Q1 2026, with operating margin collapsing to −94.1% and net margin at −82.3%, signaling severe operational stress.

• Operating margin worsened from −51.7% in Q3 2025 to −94.1% in Q1 2026, marking the steepest quarterly decline in the dataset.

• Net profit margin swung from −7.3% in Q3 2025 to −82.3% in Q1 2026, indicating a massive revenue-to-loss expansion.

• Return on assets deteriorated to −54.7% in Q1 2026 from −6.2% in Q3 2025, reflecting deepening asset inefficiency.

⚠ Q3 2025 showed near-breakeven NPM (−7.3%), suggesting a potential inflection—but Q4 2025 and Q1 2026 reversed gains decisively.

⚠ Equity and debt metrics absent across most periods; capital structure health cannot be assessed from available data.

Get alerted when VSEE's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for VSEE HEALTH, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of VSEE

ARMISTICE CAPITAL, LLC
$874.6K3,498,227 sh
GEODE CAPITAL MANAGEMENT, LLC
$109.4K437,599 sh
VANGUARD CAPITAL MANAGEMENT LLC
$53.4K213,716 sh
XTX Topco Ltd
$13.3K53,216 sh
UBS Group AG
$8.8K35,160 sh
STATE STREET CORP
$4.7K18,900 sh
Wealthcare Advisory Partners LLC
$3.5K14,098 sh
CWM, LLC
$2.1K8,316 sh
Tower Research Capital LLC (TRC)
$1.1K4,598 sh
VANGUARD FIDUCIARY TRUST CO
$543.002,171 sh

Fund	Value	Shares
ARMISTICE CAPITAL, LLC	$874.6K	3,498,227
GEODE CAPITAL MANAGEMENT, LLC	$109.4K	437,599
VANGUARD CAPITAL MANAGEMENT LLC	$53.4K	213,716
XTX Topco Ltd	$13.3K	53,216
UBS Group AG	$8.8K	35,160
STATE STREET CORP	$4.7K	18,900
Wealthcare Advisory Partners LLC	$3.5K	14,098
CWM, LLC	$2.1K	8,316
Tower Research Capital LLC (TRC)	$1.1K	4,598
VANGUARD FIDUCIARY TRUST CO	$543.00	2,171

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put VSEE on your watchlist

Track score changes the day VSEE HEALTH, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is VSEE a good stock to buy?

13F Pro's AI-powered analysis of VSEE HEALTH, INC. (VSEE) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for VSEE are available on the VSEE stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own VSEE?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling VSEE. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of VSEE HEALTH, INC.'s investment landscape.